|1.||Amagai, Masayuki: 37 articles (07/2015 - 01/2002)|
|2.||Nishikawa, Takeji: 15 articles (07/2011 - 01/2002)|
|3.||Tsunoda, Kazuyuki: 14 articles (08/2011 - 01/2002)|
|4.||Hertl, Michael: 13 articles (11/2014 - 01/2003)|
|5.||Hashimoto, Takashi: 13 articles (06/2014 - 12/2003)|
|6.||Ota, Takayuki: 12 articles (08/2011 - 01/2002)|
|7.||Koyasu, Shigeo: 9 articles (07/2011 - 01/2002)|
|8.||Aoyama, Yumi: 8 articles (06/2015 - 12/2005)|
|9.||Ishii, Norito: 8 articles (03/2014 - 09/2007)|
|10.||Nishifuji, Koji: 8 articles (04/2012 - 05/2002)|
|1.||Pemphigus (Pemphigus Vulgaris)
07/06/2000 - "Protection against pemphigus foliaceus by desmoglein 3 in neonates."
02/01/2012 - "An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris."
02/01/2002 - "The humanized SCID mouse model to study HLA class II-linked autoimmunity to desmoglein 3 in pemphigus vulgaris."
01/01/2002 - "In this study, we performed immunologic and histopathologic studies using this pemphigus vulgaris model in mice and compared the gross and microscopic phenotypes of pemphigus vulgaris model mice and desmoglein 3-/- mice. "
11/01/2015 - "This Correspondence is a Reply to Pseudo Pemphigus Phenotypes in Mice with Inactivated Desmoglein 3: Further Insight to the Complexity of Pemphigus Pathophysiology by Evgueni Kountikov et al. "
12/01/2012 - "To estimate the diagnostic accuracy of enzyme-linked immunosorbent assays (ELISA) to detect anti-BP180 and anti-desmoglein 3 (Dsg3) autoantibodies in the diagnosis of autoimmune blistering skin diseases. "
03/01/2014 - "Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are two blistering skin diseases mediated by antibodies to desmoglein 3 (Dsg3) and/or Dsg1. "
10/01/1997 - "Pemphigus vulgaris (PV) is a dermatosis mediated by autoantibodies against desmoglein 3 (Dsg3). "
06/01/1997 - "Nonsecretory IgA1 autoantibodies targeting desmosomal component desmoglein 3 in intraepidermal neutrophilic IgA dermatosis."
04/01/2012 - "Pemphigus vulgaris (PV) is an autoimmune blistering skin disease characterized by suprabasal acantholysis and by autoantibodies against desmoglein 3 localized on desmosomes. "
03/01/2015 - "Antibody blockade of desmoglein 3 function in pemphigus vulgaris patients leads to skin blistering (acantholysis) and oral mucosa lesions. "
08/01/2009 - "The desmoglein 3 (Dsg3) knockout mouse and pemphigus vulgaris (PV) mouse model present a similar type of supra-basal acantholysis, even though the subcellular mechanism is considered to be completely different. "
01/01/2002 - "Both types of mice showed suprabasilar acantholysis in the stratified squamous epithelia, including the oral mucous membranes and traumatized skin around the snout or paws; however, some pemphigus vulgaris model mice demonstrated a more severe phenotype than desmoglein 3-/- mice. "
01/01/1999 - "It is characterized by the presence of an autoantibody directed against desmoglein 3, which causes acantholysis and blister formation. "
01/01/2013 - "Though the pathogenetic role of autoantibodies directed against desmoglein 3 is certain, a number of other factors have been suggested to determine acantholysis in PV. In this study we examined the possible role of CD8+ T cells in the development of acantholysis by a passive transfer of PV autoantibodies using CD8 deficient mice, and we also studied the inflammatory infiltrate of PV skin lesions by immunohistochemical staining. "
|4.||Bullous Pemphigoid (Pemphigoid)
11/01/2004 - "Parallel fluctuation of anti-desmoglein 3 and anti-BP180 autoantibody titres in a patient with bullous pemphigoid."
07/01/2009 - "Pemphigus vulgaris with circulating anti-desmoglein 3 and anti-BP180 antibodies: a case report and brief review of cases with coexistence of pemphigus vulgaris and bullous pemphigoid."
01/01/2011 - "Direct immunofluorescence on a skin specimen and anti-desmoglein 1, anti-desmoglein 3, and anti-bullous pemphigoid antigen 180 were negative. "
10/01/2006 - "Detection of pemphigus desmoglein 1 and desmoglein 3 autoantibodies and pemphigoid BP180 autoantibodies in saliva and comparison with serum values."
06/01/2013 - "Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies."
01/01/2015 - "Furthermore, in vitro studies have demonstrated that overexpression of desmoglein 3 in cancer cell lines activates several signal pathways that have an impact on cell morphology, adhesion and locomotion. "
01/01/2015 - "However, recently several studies have shown that various desmosomal components, including desmoglein 3, are up-regulated in cancer with increased levels of expression correlating with the clinical stage of malignancy, implicating their potentiality to serve as a diagnostic and prognostic marker. "
01/01/2015 - "This review will discuss recent advances which support the role of desmoglein 3 in cancer progression. "
01/01/2015 - "Desmoglein 3: a help or a hindrance in cancer progression?"
01/01/2011 - "To our knowledge, this is the first report of PH with an associated neoplasm in which only anti-desmoglein 3 antibody was detected."
|3.||Immunoglobulin A (IgA)
|6.||Immunoglobulin G (IgG)
|9.||Proteins (Proteins, Gene)